Neuro-Oncology Reviews
Volume
26 Number 18
31 August 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 18, 31 August
Abbasi H, Alem E, Bakhshimoghaddam F, Khoshdooz S, Doaei S.
Effects of Coffee and Tea Consumption
on Glioma Risk: An Umbrella Review of Systematic Reviews and
Meta-analyses.
Clin
Nutr ESPEN. 2024 Aug 21:S2405-4577(24)01285-3. doi:
10.1016/j.clnesp.2024.08.013. PMID:
39178989. Review; Meta-analysis. ˍ
de Oliveira MPR, Sandes PHF, de Oliveira Piñeiro GT, de
Souza DCR, Nunes GSM, Dos Passos GS.
Resection
vs. coagulation of dural attachment in patients with spinal
meningioma: an updated systematic review and meta-analysis.
Acta
Neurochir (Wien). 2024 Aug 21;166(1):346. doi:
10.1007/s00701-024-06235-3. PMID:
39167255. Review˰ ˍ
Detchou D, Barrie U.
Interleukin 4 and
cancer resistance in glioblastoma multiforme.
Neurosurg
Rev. 2024 Aug 21;47(1):448. doi:
10.1007/s10143-024-02695-4. PMID:
39164434. Review˰ ˍ
Kapteijn MY, Bakker N, Koekkoek JAF, Versteeg HH, Buijs JT.
Venous Thromboembolism in Patients
with Glioblastoma: Molecular Mechanisms and Clinical Implications.
Thromb
Haemost. 2024 Aug 21. doi:
10.1055/s-0044-1789592. PMID:
39168144. Review. ˍ
Nielsen SH, Rasmussen R.
MR-guided
laser interstitial thermal therapy in the treatment of brain
tumors and epilepsy.
Acta
Neurochir (Wien). 2024 Aug 21;166(1):344. doi:
10.1007/s00701-024-06238-0. PMID:
39167226. Review˰ ˍ
*Wong CE, Chang Y, Chen PW, Huang YT, Chang YC, Chiang CH, Wang
LC, Lee PH, Huang CC, Hsu HJ, Lee JS.
Dendritic
cell vaccine for glioblastoma: an updated meta-analysis and trial
sequential analysis.
J
Neurooncol. 2024 Aug 21. doi:
10.1007/s11060-024-04798-w. PMID:
39167243. Meta-analysis˰
ˍ
Lan J, Ren Y, Liu Y, Chen L, Liu J.
A
bibliometric analysis of radiation-induced brain injury: a
research of the literature from 1998 to 2023.
Discov
Oncol. 2024 Aug 22;15(1):364. doi:
10.1007/s12672-024-01223-6. PMID:
39172266. Bibliometric analysis. ˍ
Lei J, Liu Y, Fan Y.
The effects of
dabrafenib and/or trametinib treatment in Braf V600-mutant glioma:
a systematic review and meta-analysis.
Neurosurg
Rev. 2024 Aug 22;47(1):458. doi:
10.1007/s10143-024-02664-x. PMID:
39172230. Review; Meta-analysis. ˍ
Testa U, Castelli G, Pelosi E.
CAR-T
Cells in the Treatment of Nervous System Tumors.
Cancers
(Basel). 2024 Aug 22;16(16):2913. doi:
10.3390/cancers16162913. PMID:
39199683. Review. ˍ
Newton HB.
Indian Ayurvedic medicine:
Overview and application to brain cancer.
J
Ayurveda Integr Med. 2024 Aug 23;15(4):101013. doi:
10.1016/j.jaim.2024.101013. PMID:
39181067. Review. ˍ
Wijaya W, Phyu SM, Jiang S.
Extracellular
Vesicle (EV) Survivin for Cancer Diagnostics and Therapeutics: A
Review.
Front
Biosci (Landmark Ed). 2024 Aug 22;29(8):302. doi:
10.31083/j.fbl2908302. PMID:
39206911. Review. ˍ
Otth M, Weiser A, Lee SY, Rudolf von Rohr L, Heesen P, Guerreiro
Stucklin AS, Scheinemann K.
Treatment
of Medulloblastoma in the Adolescent and Young Adult Population: A
Systematic Review.
J
Adolesc Young Adult Oncol. 2024 Aug 23. doi:
10.1089/jayao.2024.0044. PMID:
39178158. Review˰ ˍ
Dakal TC, Kakde GS, Maurya PK.
Genomic,
epigenomic and transcriptomic landscape of glioblastoma.
Metab
Brain Dis. 2024 Aug 24. doi:
10.1007/s11011-024-01414-8. PMID:
39180605. Review˰ ˍ
Roy A, Shashidhar A, Birua GJS, Rao S, Kulanthaivelu K,
Arimappamagan A.
Metachronous
intracranial meningiomas without dural attachment in a child -
Rare case report and review of literature.
Childs
Nerv Syst. 2024 Aug 24. doi:
10.1007/s00381-024-06582-7. PMID:
39180697. Case report; Review˰
ˍ
*Friess D, Brauer S, Pöysti A, Choudhury C, Harris L.
Tools
to study neural and glioma stem cell quiescence.
Trends
Neurosci. 2024 Aug 26:S0166-2236(24)00129-2. doi:
10.1016/j.tins.2024.07.004. PMID:
39191628. Review˰ ˍ
Wang W, Ou Z, Huang X, Wang J, Li Q, Wen M, Zheng L.
Microbiota
and glioma: a new perspective from association to clinical
translation.
Gut
Microbes. 2024 Aug 26;16(1):2394166. doi:
10.1080/19490976.2024.2394166. PMID:
39185670. Review. ˍ
Albert NL, Le Rhun E, Minniti G, Mair MJ, Galldiks N, Tolboom N,
Jakola AS, Niyazi M, Smits M, Verger A, Cicone F, Weller M,
Preusser M; European Organisation for Research and Treatment of
Cancer Brain Tumor Group.
Translating
the theranostic concept to
neuro-oncology: disrupting barriers.
Lancet
Oncol. 2024 Aug 27;25(9):e441-e451. doi:
10.1016/S1470-2045(24)00145-1. PMID:
39214115. Review˰ ˍ
Detchou D, Barrie U.
Circulating
biomarkers literature in glioma patient populations.
Neurosurg
Rev. 2024 Aug 27;47(1):484. doi:
10.1007/s10143-024-02738-w. PMID:
39187709. Review˰ ˍ
Hinojosa J, Becerra V, Candela-Cantó S, Alamar M, Culebras
D, Valencia C, Valera C, Rumiá J, Muchart J, Aparicio J.
Extra-temporal pediatric low-grade
gliomas and epilepsy.
Childs
Nerv Syst. 2024 Aug 27. doi:
10.1007/s00381-024-06573-8. PMID:
39191974. Review˰ ˍ
Karschnia P, Gerritsen JKW, Teske N, Cahill DP, Jakola AS, van den
Bent M, Weller M, Schnell O, Vik-Mo EO, Thon N, Vincent AJPE, Kim
MM, Reifenberger G, Chang SM, Hervey-Jumper SL, Berger MS, Tonn
JC.
The oncological role of
resection in newly diagnosed diffuse
adult-type glioma defined by the WHO 2021
classification: a Review by the RANO
resect group.
Lancet
Oncol. 2024 Sep;25(9):e404-e419. doi:
10.1016/S1470-2045(24)00130-X. PMID:
39214112. Review. ˍ
Süß P, Diebold M, Sankowski R.
Advances
in understanding the immunity of the brain and its borders: Focus
on brain macrophages.
Clin
Transl Med. 2024 Aug 27;14(9):e70014. doi:
10.1002/ctm2.70014. PMID:
39192506. Review. ˍ
Ayasa LA, Rahhal S, Najjar AK, Suboh BN, Aliwaiai M, Daqour AM,
Bakri I.
Glioblastoma multiforme in a
patient with neurofibromatosis type 1: a case report and review of
literature.
J
Surg Case Rep. 2024 Aug 28;2024(8):rjae517. doi:
10.1093/jscr/rjae517. PMID:
39211378. Case report; Review. ˍ
Ghosh MK, Kumar S, Begam S, Ghosh S, Basu M.
GBM
immunotherapy: Exploring molecular and clinical frontiers.
Life
Sci. 2024 Aug 28;356:123018. doi:
10.1016/j.lfs.2024.123018. PMID:
39214286. Review˰ ˍ
Da Ros V, Filippi L, Garaci F.
Intra-arterial
administration of PSMA-targeted radiopharmaceuticals for brain
tumors: is the era of interventional theranostics next?
Expert
Rev Anticancer Ther. 2024 Aug 29:1-5. doi:
10.1080/14737140.2024.2398492. PMID:
39206859. Review˰ ˍ
Dezena RA, Correia MM, Fujita LGA, de Souza DG, Pereira LFA,
Alberto GB, Marcolino LCM, Xavier LB, Silveira SPP.
Upper
brainstem pediatric low-grade gliomas: review and neuroendoscopic
approach.
Childs
Nerv Syst. 2024 Aug 29. doi:
10.1007/s00381-024-06527-0. PMID:
39207527. Review˰ ˍ
Zhu H, Allwin C, Bassous MG, Pouliopoulos AN.
Focused
ultrasound-mediated enhancement of blood-brain barrier
permeability for brain tumor treatment: a systematic review of
clinical trials.
J
Neurooncol. 2024 Aug 29. doi:
10.1007/s11060-024-04795-z. PMID:
39207625. Review. ˍ
Andrew Awuah W, Shah MH, Tan JK, Ranganathan S, Sanker V, Darko K,
Tenkorang PO, Adageba BB, Ahluwalia A, Shet V, Aderinto N, Kundu
M, Abdul-Rahman T, Atallah O.
Immunotherapeutic
advances in glioma management: The rise of vaccine-based
approaches.
CNS
Neurosci Ther. 2024 Aug 30;30(9):e70013. doi:
10.1111/cns.70013. PMID:
39215399. Review. ˍ
Garofalo S, D'Alessandro G, Limatola C.
Microglia
in Glioma.
Adv
Neurobiol. 2024 Aug 30;37:513-527. doi:
10.1007/978-3-031-55529-9_28. PMID:
39207710. Review˰ ˍ
Lastrucci A, Morelli I, Votta C, Maran I, Iosca N, Monaco IP,
Salvestrini V, Desideri I, Marrazzo L, Wandael Y, Cornacchione P,
Pallotta S, Giansanti D, Ricci R, Livi L, Bonomo P.
Open-Face
Masks in Radiotherapy: Enhancing Therapeutic Strategies for Head
and Neck and Brain Cancer Patients-A Comprehensive Scoping Review.
Cancers
(Basel). 2024 Aug 21;16(16):2899. doi:
10.3390/cancers16162899. PMID:
39199669. Review. ˍ
Rolfe NW, Dadario NB, Canoll P, Bruce JN.
A
Review of Therapeutic Agents Given by Convection-Enhanced Delivery
for Adult Glioblastoma.
Pharmaceuticals
(Basel). 2024 Jul 23;17(8):973. doi:
10.3390/ph17080973. PMID:
39204078. Review. ˍ
*Phung LH, Nejo T, Okada H.
Lessons
from Post-Immunotherapy Tumor Tissues in Clinical Trials: How Can
We Fuel the Tumor Microenvironment in Gliomas?
Vaccines
(Basel). 2024 Aug 1;12(8):862. doi:
10.3390/vaccines12080862. PMID:
39203988. Review. ˍ
Hogan A, Mut M.
Neurosteroids in
Glioma: A Novel Therapeutic Concept.
Life
(Basel). 2024 Aug 2;14(8):975. doi:
10.3390/life14080975. PMID:
39202716. Review. ˍ
Schiera G, Di Liegro CM, Vento F, Di Liegro I.
Role
of Extracellular Vesicles in the Progression of Brain Tumors.
Biology
(Basel). 2024 Aug 2;13(8):586. doi:
10.3390/biology13080586. PMID:
39194524. Review. ˍ
Bonada M, Pittarello M, De Fazio E, Gans A, Alimonti P, Slika H,
Legnani F, Di Meco F, Tyler B.
Pediatric
Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of
the Literature on Biological Features and New Therapeutic
Strategies.
Genes
(Basel). 2024 Aug 6;15(8):1038. doi:
10.3390/genes15081038. PMID:
39202398. Review. ˍ
Esparragosa Vazquez I, Ducray F.
The
Role of Radiotherapy, Chemotherapy, and Targeted Therapies in
Adult Intramedullary Spinal Cord Tumors.
Cancers
(Basel). 2024 Aug 6;16(16):2781. doi:
10.3390/cancers16162781. PMID:
39199553. Review. ˍ
Sulangi AJ, Husain A, Lei H, Okun J.
Neuronavigation
in glioma resection: current applications, challenges, and
clinical outcomes.
Front
Surg. 2024 Aug 6;11:1430567. doi:
10.3389/fsurg.2024.1430567. PMID:
39165667. Review. ˍ
*Lv K, Du X, Chen C, Yu Y.
Research
hotspots and trend of glioblastoma immunotherapy: a bibliometric
and visual analysis.
Front
Oncol. 2024 Aug 7;14:1361530. doi:
10.3389/fonc.2024.1361530. PMID:
39175478 Bibliometric analysis. ˍ
Aebisher D, Woźnicki P, Czarnecka-Czapczyńska M,
Dynarowicz K, Szliszka E, Kawczyk-Krupka A, Bartusik-Aebisher D.
Molecular Determinants for
Photodynamic Therapy Resistance and Improved Photosensitizer
Delivery in Glioma.
Int
J Mol Sci. 2024 Aug 9;25(16):8708. doi:
10.3390/ijms25168708. PMID:
39201395. Review. ˍ
Luo M, Luan X, Yang C, Chen X, Yuan S, Cao Y, Zhang J, Xie J, Luo
Q, Chen L, Li S, Xiang W, Zhou J.
Revisiting
the potential of regulated cell death in glioma treatment: a focus
on autophagy-dependent cell death, anoikis, ferroptosis,
cuproptosis, pyroptosis, immunogenic cell death, and the crosstalk
between them.
Front
Oncol. 2024 Aug 9;14:1397863. doi:
10.3389/fonc.2024.1397863. PMID:
39184045. Review. ˍ
Pennisi G, Bruzzaniti P, Burattini B, Piaser Guerrato G, Della
Pepa GM, Sturiale CL, Lapolla P, Familiari P, La Pira B, D'Andrea
G, Olivi A, D'Alessandris QG, Montano N.
Advancements
in Telomerase-Targeted Therapies for Glioblastoma: A Systematic
Review.
Int
J Mol Sci. 2024 Aug 9;25(16):8700. doi:
10.3390/ijms25168700. PMID:
39201386. Review. ˍ
Hwang YK, Lee DH, Lee EC, Oh JS.
Importance
of Autophagy Regulation in Glioblastoma with Temozolomide
Resistance.
Cells.
2024 Aug 11;13(16):1332. doi:
10.3390/cells13161332. PMID:
39195222. Review. ˍ
Gawel AM, Betkowska A, Gajda E, Godlewska M, Gawel D.
Current
Non-Metal Nanoparticle-Based Therapeutic Approaches for
Glioblastoma Treatment.
Biomedicines.
2024 Aug 11;12(8):1822. doi:
10.3390/biomedicines12081822. PMID:
39200286. Review. ˍ
Huang T, Ren X, Tang X, Wang Y, Ji R, Guo Q, Ma Q, Zheng Y, Hu Z,
Zhou Y.
Current perspectives and trends
of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a
bibliometric analysis.
Front
Immunol. 2024 Aug 12;15:1427380. doi:
10.3389/fimmu.2024.1427380. PMID:
39188712. Bibliometric analysis. ˍ
Ma M, Fei X, Jiang D, Chen H, Xie X, Wang Z, Huang Q.
Research
Progress on the Mechanism of Histone Deacetylases in Ferroptosis
of Glioma.
Oncol
Rev. 2024 Aug 12;18:1432131. doi:
10.3389/or.2024.1432131. PMID:
39193375. Review. ˍ
Du L, Zhang Q, Li Y, Li T, Deng Q, Jia Y, Lei K, Kan D, Xie F,
Huang S.
Research progress on the role
of PTEN deletion or mutation in the immune microenvironment of
glioblastoma.
Front
Oncol. 2024 Aug 14;14:1409519. doi:
10.3389/fonc.2024.1409519. PMID:
39206155. Review. ˍ
Grimi A, Bono BC, Lazzarin SM, Marcheselli S, Pessina F, Riva
M.
Gliomagenesis, Epileptogenesis, and
Remodeling of Neural Circuits: Relevance for Novel Treatment
Strategies in Low- and High-Grade Gliomas.
Int
J Mol Sci. 2024 Aug 16;25(16):8953. doi:
10.3390/ijms25168953. PMID:
39201639. Review. ˍ
Mehta NH, Prajapati M, Aeleti R, Kinariwala K, Ohri K, McCabe S,
Buller Z, Leskinen S, Nawabi NL, Bhatt V, Yerigeri K, Babaria V.
The Power of a Belief System: A
Systematic Qualitative Synthesis of Spiritual Care for Patients
with Brain Tumors.
J
Clin Med. 2024 Aug 18;13(16):4871. doi:
10.3390/jcm13164871. PMID:
39201013. Review. ˍ
Tsuchiya T, Kawauchi D, Ohno M, Miyakita Y, Takahashi M,
Yanagisawa S, Osawa S, Fujita S, Omura T, Narita Y.
Risk
Factors of Distant Recurrence and Dissemination of IDH
Wild-Type Glioblastoma: A Single-Center Study and Meta-Analysis.
Cancers
(Basel). 2024 Aug 18;16(16):2873. doi:
10.3390/cancers16162873. PMID:
39199644. Observational study; Meta-analysis. ˍ
Scalia G, Ferini G, Graziano F, Marrone S, Giurato E, Galasso MG,
Atallah O, Farooq M, Furnari M, Umana GE, Nicoletti
GF.
Intraventricular Glioblastomas: A
Systematic Review of Multimodal Treatment Strategies.
Ann
Ital Chir. 2024 Aug 20;95(4):416-434. doi:
10.62713/aic.3529. PMID:
39186332. Review. ˍ
Shah S, Lucke-Wold B.
Image-Guided
Mesenchymal Stem Cell Sodium Iodide Symporter (NIS) Radionuclide
Therapy for Glioblastoma.
Cancers
(Basel). 2024 Aug 20;16(16):2892. doi:
10.3390/cancers16162892. PMID:
39199662. Review. ˍ